Dr. Harpel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
45 W 54th St
3C
New York, NY 10019Phone+1 917-584-6499Fax+1 212-918-9393
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2001 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- New York University School of MedicineClass of 1998
Certifications & Licensure
- NY State Medical License 1999 - 2027
- NJ State Medical License 2011 - 2017
Publications & Presentations
PubMed
- 13 citationsSafety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.Michael W. Schuster, Tsiporah B. Shore, John G. Harpel, June Greenberg, Bita Jalilizeinali
Supportive Care in Cancer. 2008-05-01 - 678 citationsAn assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase constructMayumi Abe, John G. Harpel, C.N. Metz, Irene Nunes, D.J. Loskutoff
Analytical Biochemistry. 1994-02-01 - 90 citationsStem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple MyelomaTomer M Mark, Jessica L. Stern, Jessica R. Furst, David Jayabalan, Faiza Zafar
Biology of Blood and Marrow Transplantation. 2008-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: